Effectiveness and safety of ustekinumab for patients with ulcerative colitis: A single-centre retrospective study

被引：0
|
作者：
Kimura, M. [1 ]
Shimizu, M. [1 ]
Shirai, M. [1 ]
Sakaguchi, Y. [1 ]
Kobayashi, K. [1 ]
Iruya, R. [1 ]
Seki, S. [1 ]
Naitou, D. [1 ]
Nishimiya, T. [1 ]
Oouchi, Y. [1 ]
Shibamoto, M. [1 ]
Iwashita, H. [1 ]
Miyamura, M. [1 ]
Kikuchi, H. [1 ]
Yamada, A. [1 ]
Nakamura, K. [1 ]
Matsuoka, K. [1 ]
机构：
[1] Toho Univ, Gastroenterol, Sakura Med Ctr, Sakura, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P796
引用
收藏
页码：927 / 928
页数：2
相关论文
共 50 条
  • [1] Cyclosporin A efficacy in a paediatric ulcerative colitis: a retrospective single-centre study
    Osiecki, M.
    Dadalski, M.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S297 - S298
  • [2] Real-World Effectiveness And Safety Of Ustekinumab In Patients With Ulcerative Colitis: A Multi-Centre Study
    Parakkal, D.
    Johnson, A.
    Fenster, M.
    Ramos, G.
    Zulqarnain, M.
    Ullman, T.
    Huang, L.
    Gutierrez, A.
    Bruss, A.
    Ungaro, R.
    Cohen, B.
    Gaurav, S.
    Anish, P.
    Sasankan, P.
    Costable, N.
    Pekow, J.
    Wang, W.
    Rubin, D.
    Ciorba, M.
    Beniwal-Patel, P.
    Loftus, E.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S349 - S350
  • [3] Cyclosporine versus infliximab in patients with Acute Severe Ulcerative Colitis: A single-centre retrospective study
    Karpaviciute, V.
    Kiudelis, G.
    Kupcinskas, J.
    Kupcinskas, L.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 600 - 601
  • [4] Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study
    Uchida, Hideaki
    Kamata, Masahiro
    Ishikawa, Takeko
    Ito, Makoto
    Watanabe, Ayu
    Egawa, Shota
    Hiura, Azusa
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Tada, Yayoi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1455 - E1457
  • [5] Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study
    Parra, Rogerio Serafim
    Chebli, Julio Maria Fonseca
    de Azevedo, Matheus Freitas Cardoso
    Chebli, Liliana Andrade
    Zabot, Gilmara Pandolfo
    Cassol, Ornella Sari
    Froes, Renata de Sa Brito
    Santana, Genoile Oliveira
    Lubini, Marcio
    Magro, Daniela Oliveira
    Imbrizi, Marcello
    Moraes, Antonio Carlos da Silva
    Teixeira, Fabio Vieira
    Alves Jr, Antonio Jose Tiburcio
    Gasparetti Jr, Newton Luiz Tricarico
    Ferreira, Sandro da Costa
    Queiroz, Natalia Sousa Freitas
    Kotze, Paulo Gustavo
    Feres, Omar
    CROHNS & COLITIS 360, 2024, 6 (02)
  • [6] Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
    Nomura, Kei
    Shibuya, Tomoyoshi
    Odakura, Rina
    Haraikawa, Mayuko
    Ishino, Hirotaka
    Orikasa, Masayuki
    Omori, Masashi
    Koma, Masao
    Ito, Kentaro
    Maruyama, Takafumi
    Nomura, Osamu
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2024, 12 (09)
  • [7] Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
    Fumery, Mathurin
    Filippi, Jerome
    Abitbol, Vered
    Biron, Amelie
    Laharie, David
    Serrero, Melanie
    Altwegg, Romain
    Bouhnik, Yoram
    Peyrin-Biroulet, Laurent
    Gilletta, Cyrielle
    Roblin, Xavier
    de Chambrun, Guillaume Pineton
    Vuitton, Lucine
    Bourrier, Anne
    Nancey, Stephane
    Gornet, Jean-Marc
    Nahon, Stephane
    Bouguen, Guillaume
    Viennot, Stephanie
    Nachury, Maria
    Amiot, Aurelien
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (07) : 944 - 951
  • [8] Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study
    Ando, Katsuyoshi
    Fujiya, Mikihiro
    Ueno, Nobuhiro
    Ito, Takahiro
    Maemoto, Atsuo
    Nasuno, Masanao
    Tanaka, Hiroki
    Sakurai, Kensuke
    Katsurada, Takehiko
    Orii, Fumika
    Ashida, Toshifumi
    Motoya, Satoshi
    Kazama, Tomoe
    Yokoyama, Yoshihiro
    Hirayama, Daisuke
    Nakase, Hiroshi
    CROHNS & COLITIS 360, 2024, 6 (02)
  • [9] Long-term effectiveness and safety of ustekinumab dose escalation in patients with refractory ulcerative colitis: a multicenter retrospective cohort study
    Van Lierop, L.
    Albino, L.
    Rosentreter, R.
    Thomas, P. W. A.
    Lu, C.
    Siffledeen, J.
    Kroeker, K., I
    Ma, C.
    Peerani, F.
    Halloran, B. P.
    Baumgart, D. C.
    Dieleman, L. A.
    Du, L.
    Hoentjen, F.
    Wong, K.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1196 - i1196
  • [10] Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
    Tursi, Antonio
    Mocci, Giammarco
    Scaldaferri, Franco
    Napolitano, Daniele
    Maresca, Rossella
    Pugliese, Daniela
    Semprucci, Gianluca
    Savarino, Edoardo
    Cuomo, Antonio
    Donnarumma, Laura
    Bodini, Giorgia
    Pasta, Andrea
    Maconi, Giovanni
    Cataletti, Giovanni
    Pranzo, Giuseppe
    Rodino, Stefano
    Sebkova, Ladislava
    Costa, Francesco
    Ferronato, Antonio
    Gaiani, Federica
    Marzo, Manuela
    Luppino, Ileana
    Fabiano, Giulia
    Paese, Pietro
    Elisei, Walter
    Monterubbianesi, Rita
    Faggiani, Roberto
    Grossi, Laurino
    Serio, Mariaelena
    Scarcelli, Antonella
    Lorenzetti, Roberto
    Allegretta, Leonardo
    Chiri, Stefania
    Grasso, Giuseppina
    Antonelli, Elisabetta
    Bassotti, Gabrio
    Spagnuolo, Rocco
    Luzza, Francesco
    Fanigliulo, Libera
    Rocco, Giulia
    Sacchi, Carlotta
    Zampaletta, Costantino
    Rocchi, Chiara
    Bolognini, Laura
    Bendia, Emanuele
    Bianco, Maria Antonia
    Capone, Pietro
    Meucci, Costantino
    Colucci, Raffaele
    Tonti, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (1-2) : 101 - 109
12345